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Abstract 
Background: Pygopus was initially validated as a co-activator for the 
canonical Wnt signaling pathway, a critical intracellular cascade implicated both in 
development and cancer. Further studies indicated that Pygopus appears to have 
both Wnt-dependent and Wnt-independent functions. Our lab has demonstrated 
that human Pygopus 2 (hPygo2) was overexpressed and required for Epithelial 
Ovarian Cancer cell growth in the absence of Wnt signaling. Purpose: The 
purpose of this thesis was to investigate the mechanism of Wnt-independent 
requirement of hPygo2 for Epithelial Ovarian Cancer cell growth. 
Hypothesis and Objectives: I hypothesized that hPygo2 achieves Wnt-
independent functions in Epithelial Ovarian Cancer via interacting with protein 
factors not related to Wnt signaling. Therefore, three objectives were proposed in 
this thesis: 1) to determine minimal domain(s) of hPygo2 required for Wnt-
independent Epithelial Ovarian Cancer cell growth; 2) to identify potential protein 
factors that interact with this critical domain; and 3) to characterize the identified 
interactions. 
Results: Objective 1). The transfection of hPygo2-specific antisense 
oligonucleotides in Wnt-inactive Epithelial Ovarian Cancer cell line, SKOV-3 led 
to cell growth arrest, as shown previously. To assess the sequence requirements of 
hPygo2 for SKOV-3 cell growth, plasmids encoding various mutant hPygo2 with 
site-specific alterations within the transcriptional activation domain (N-terminal 
Homology Domain, NHD) or Wnt-mediating domain (Plant Homeodomain, PHD) 
were transfected in the hPygo-2-specific antisense treated SKOV-3 cells. Like 
wild-type hPygo2, mutant hPygo2 proteins with alterations in the PHD that 
prevented their Wnt-mediating ability restored the growth levels of antisense-
treated SKOV-3 cells. On the other hand, hPygo2 protein with mutations in the 
transcriptional activation NHD domain, failed to restore cell growth. Objective 2). 
Using a proteomics approach, I identified several possible proteins including p68, 
RNA helicases 11/Gu, Nop56, and Treacle protein from SKOV-3 nuclear extracts 
that bound to the NHD domain. Objective 3). The treacle protein was identified to 
have the highest probability of interaction with hPygo2. This interaction was 
confirmed in vitro and in vivo, in cancer cells. Immunofluorescence assays 
indicated that Treacle colocalized with hPygo2 in the nucleoli of SKOV-3 and 
HeLa cancer cells. Actinomycin D treatment in HeLa cells suggested that hPygo2 
is a fibrillar component of the nucleolus and may be involved in transcription or 
early modification of premature ribosomal RNAs. 
Conclusions: The NHD, but not the PHD domain, of hPygo2 protein is 
required for Wnt-independent SKOV-3 cell proliferation. The hPygo2 interacts 
with Treacle through its NHD domain and co-localizes with Treacle to the fibrillar 
compartment of nucleolus in cancer cells. Thus, these results suggest one of the 
Wnt-independent functions ofhPygo2 is involved in ribosomal biogenesis. 
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Chapter 1: Introduction 
CHAPTER! 
INTRODUCTION 
1.1 Pygopus, a Crucial Component Originally Identified in Wnt 
Signaling 
Pygopus was initially identified as a co-activator for the canonical 
Wnt signaling pathway, a critical intracellular cascade implicated both in 
development and cancer. Given its central role in the Wnt signaling pathway, I 
would like to first discuss the Wnt signaling pathway and its biological 
implications. 
1.1.1 Wnt Signal Transduction Pathways 
The mouse proto-oncogene int-I was originally identified as a 
mammalian homolog of the segment polarity gene Wingless in Drosophila 
(Nusslein-Volhard and Wieschaus, 1980; Cabrera et al., 1987; Rijsewijk et al., 
1987). The name "Wnt", derived from terms "Wingless" and "int-1 ", was then 
used to describe a cluster of metazoan genes which encode protein ligands that can 
trigger a number of intracellular cascade events. In the past two decades, the Wnt 
gene family has been expanded to 19 members in the human genome including 
Wntl, Wnt3a, Wnt8 (Katoh, 2002). The ligands encoded by these Wnt genes are 
evolutionarily conserved glycoproteins that have similar amino acid sequences 
normally with 22-24 cysteine residues (Katoh, 2002). They function via directly 
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binding to a 7 -trans-membrane Frizzled (Fzl) receptor family (Bhanot et al., 1996). 
Given that at least 10 Frizzled protein isoforms have been found, the combination 
of Wnt ligands binding to Fzl receptors is intricate and not well characterized 
(reviewed by van Amerongen et al., 2008). The other family of co-receptors that 
Wnt ligands bind to is the low-density lipoprotein receptor-related proteins (LRP) 
corresponding to Arrow in Drosophila and LRP5 and 6 in vertebrates (He et al., 
2004a; Wehrli et al., 2000). 
The different combinations of Wnt!Fzl!LRP binding complexes can 
activate various intracellular pathways (reviewed by van Amerongen et al., 2008). 
The most well characterized one involves a key transducer ~-catenin, referred to as 
the canonical Wnt signaling pathway or the Wnt/~-catenin signaling pathway. 
Pygopus has been implicated only in the canonical Wnt/~-catenin pathway. The 
other pathways which are activated without the participation of ~-catenin, defined 
as non-canonical Wnt signaling pathways, are not discussed here. Unless 
otherwise specified, therefore, the phrase "Wnt signaling" will imply "canonical 
Wnt signaling pathway" in the following sections. 
~-catenin has a role in epithelia as a component of cell adherens 
junctions. It is stably bound to the cell membrane proteins of the cadherin family 
in the absence of Wnt ligand, thus participating in cell adhesion (Kemler, 1993; 
Hulsken et el., 1994; Huber et al., 1997; Wheelock and Johnson, 2003). In the 
- 2-
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absence of ligand binding, the "off' stage of Wnt signaling (Figure 1.1A), the 
surplus newly synthesized cytoplasmic ~-catenin not associated with cadherin 
molecules, is targeted by a destruction complex that includes two scaffolding 
proteins, Axin and Adenomatous £olyposis Coli (APC). These two proteins 
facilitate two kinases, Glycogen Synthase Kinase-3 beta (GSK-3~), and Casein 
Kinase I (CK-1) to phosphorylate theN-terminal region of cytoplasmic ~-catenin 
at residues Ser-45, Ser-33, Ser-37, and Thr-41 sequentially (Amit et al., 2002; Van 
Noort et al., 2002; Wu and He, 2006). Phosphorylated cytoplasmic ~-catenin 
forms a complex with !l:!ransducing repeat-Qontaining Qrotein W-TrCP) and 
ubiquitin proteins for proteosome-mediated degradation (Amit et al., 2002; 
Kishida et al., 1998; Patel and Woodgett, 2008; Peifer et al., 2000; Piao et al., 2008; 
Willert et al., 1999). As a result of this phosphorylation/degradation mechanism, 
cytoplasmic ~-catenin is maintained at a low level in the absence of Wnt ligand. 
The binding of Wnt ligands to FrzJLRP receptors activates a Frz-
interaction protein known as Dishevelled (Dsh) (Figure l.lB). Furthermore, Wnt 
stimulation leads to phosphorylation of the LRP6 receptor at £ro-£ro-£ro-
~erTrp )£ro (PPP(S/T)P) amino acid residues where it may anchor the Axin 
protein to the plasma membrane (Tarnai et al., 2004; Tolwinski et al., 2003) and 
additional evidence suggests direct contact between Dsh and Axin proteins 
- 3 -
Figure 1.1 Canonical Wnt signal transduction pathway. A. "off' Stage of 
Wnt Signaling: ~-catenin is either asscociated with cell membrane or 
degraded upon proteosome-mediated means following the phosphorylation by 
Axin/APC/GSK-3WCK-I scaffolding complex and the addition of ~-TrCP and 
ubiquitin. B. "on" Stage of Wnt Signaling: The binding of available Wnt 
ligands to receptors (Fzl and Lrp) leads to the activation of Dsh and then the 
inhibition of the degradation complex, and ultimatedly results in the 
accumulation and translocation of ~-catenin into the nucleus to activate Wnt 
target genes by recruiting BCL-9 and Pygo to form the TCF/ ~-catenin 
transcriptional complex. 
Wnt signaling pathway 
···~·blquitin -+ 
p 
Cytoplasm 
Nucleus Nucleus 
A. ·orr stage ot Wnt signal pathway B. ·an· stage ot Wnt signal pathway 
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following Wnt ligand/receptor binding (Piao et al., 2008; Zeng et al., 2008). 
Regardless, the activation of Dsh and its association with Axin are events that 
inhibit the assembly of the disruption complex (Axin, APC, and GSK-3~), which 
relieves cytosolic ~-catenin from phosphorylation/degradation (Schwarz-Romond 
et al., 2007; Zeng et al., 2008). Unphosphorylated ~-catenin can consequently 
accumulate in the cytoplasm and enter into the nucleus by a mechanism that is not 
fully understood. In the nucleus, stabilized ~-catenin activates Wnt target genes 
through interaction with T -fell factor (TCF) DNA binding proteins. In the absence 
of Wnt stimulation, TCF forms a complex with Groucho as a repressor of target 
genes since the functional interaction between Groucho and the histone 
deacetylase (HDAC) protein Rpd3, may impede access of the basal transcriptional 
activation complex to DNA (Cavallo et al., 1998; Chen et al., 1999). During Wnt 
signaling, ~-catenin enters into the nucleus, binds to TCF, and switches the 
TCF /Groucho complex in a transcriptional repression mode to an activation mode 
by recruiting multiple cofactors. Of these cofactors, the Histone acetyltransferase 
CBP/p300 and a chromatin remodeling component Brg-1 are proposed to interact 
with TCF /~-catenin comlex and facilitate Wnt target gene transcription by 
inducing chromatin remodeling (Barker et al., 2001 ; Hecht et al., 2000). The 
recruitment of Pygopus as a co-activator to the ~-catenin/TCF transcriptional 
complex under the mediation ofBCL-9 protei n (Figure 1.2) is required for the 
- 5 -
Figure 1.2 ~-catenin/TCF Transcriptional Complex in the Canonical Wnt 
Signaling pathway. The complex composes of TCF, ~-catenin, BCL-9, and 
hPygo2. The PHD domain (in brown color) of hPygo2 interacts with HD-1 
domain of BCL-9 and associates with the complex for Wnt signaling. NHD 
domain (blue color) of hPygo2 may contain strong transcriptional activity by 
recruiting unknown factors. 
~anscriptio a Comple 
Nucleu 
• - N~lea Localiza~on SeqLJence (NLS) 
- N-tenninal Homology Domain (NHD) 
• - Planl Homeodoma·n (PHD) 
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activation of canonical Wnt signaling pathway (Hoffmans et al, 2005; Stadeli and 
Basler, 2005). 
To evaluate the exact consequences associated with active Wnt 
signaling, Wnt target genes have been intensely researched in the last 20 years. 
These target genes include those that encode yascular ~ndothelial growth factor 
(VEGF) (Zhang et al., 2001) and .fibroblast growth factors (FGFs) (Chamorro et 
al., 2005); cyclin D 1 (Tetsu and McCormick, 1999) and MYC (He et al., 1998), 
both of which can regulate cell growth and proliferation; siamois (Carnac et al., 
1996; Lemaire et al., 1995) and brachyury (Arnold et al., 2000; Smith et al., 1991), 
which regulate cell differentiation during embryonic development. Some Wnt 
signaling pathway components such as Axin, Fzl, LRPs, and TCFs can also be 
target genes for autoregulating feedback (reviewed by Klaus and Birchmeier, 2008; 
http://www.stanford.edu/~rnusse/wntwindow.html). In Drosophila, the naked 
cutical (nkd) gene containing Wingless responsive ~lements (WREs) was well 
characterized not only as a target gene activated by Wnt signaling but also as a 
feedback antagonist to regulate Wnt signaling (Chang et al., 2008; Zeng et al., 
2000). 
1.1.2 Wnt Signaling in Development 
The Wnt signal transduction pathway plays evolutionarily 
conserved and critical roles in animal development by controlling biological 
-7-
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programs of embryonic development and adult tissue homeostasis (Reviewed in 
Klaus and Birchmeier, 2008; Grigoryan et al., 2008). 
The implications of Wnt signaling in embryonic development were 
mostly determined by the analysis of different animal embryos that contain gain-
or loss-of-function mutant Wnt proteins or pathway components. For instance, the 
Wingless (Wg, Wntl homolog in Drosophila) mutant fly embryos displayed 
abnormal patterning in the overlying ventral cuticle, similar to that observed in 
embryos with mutations on Wnt signaling components such as Dsh and Amadillo 
(the Drosophila homolog of ~-catenin), suggesting that Wnt signaling is require 
for normal segmentation and polarity in Drosophila (Niisslein-Volhard and 
Wieschaus, 1980). Xenopus embryos are also widely used as models to study the 
effects of Wnt signaling in vertebrate development. The injection of mRNAs that 
encode signaling positive regulators including Wntl , Dsh, ~-catenin or dominant-
negative versions of GSK-3~ into the 4 celled embryo of Xenopus resulted in 
duplicated Axis formation (McMahon and Moon, 1989; Dominguez et al., 1995; 
Guger and Gumbiner, 1995; Behrens et al., 1996) whereas injections of pathway 
inhibitors such as Axin led to the loss of primary axis formation (Zeng et al., 1997; 
Behrens et al., 1998). These studies implied that dysregulation of Wnt signaling 
affected normal development of the body axis. 
Wnt3a, one of the ligands that activate Wnt signaling, was 
- 8-
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elucidated as a regulator for the posterior development of mouse embryos. It 
regulates axis patterning and J2.re§.omitic mesoderm (PSM) formation, and directs 
the segmentation of presomitic mesoderm into somites by targeting the segment 
boundary determination genes Mesp2 and Ripply2 in the PSM (Dunty et al., 2008; 
Nakaya et al., 2005). 
The roles of Wnt signaling in the specification and maintenance of 
stem cells in various adult organs were revealed in transgenic mice with 
conditional loss- or gain-of-function mutations of ~-catenin. The affected tissues 
and organs included skin appendages (hair follicles and teeth), central nervous 
system, heart, bone, neural crest, eye, gastrointestinal tract, kidney, mammary 
gland, hematopoietic system and other organs (Reviewed in Grigoryan et al., 
2008). For instance, transgenic mice containing loss-of-function mutant ~-catenin 
displayed the formation of cysts instead of hair follicles by inhibiting the 
production of hair progenitor cells (Huelsken et al., 2001 ). More further analysis 
of gain-of-function mutation of ~-catenin revealed increased hair cell progenitors 
and demonstrated that the Wnt signaling regulates the bulge stem cell of the hair 
follicle to specify the hair cell fate (Ito et al., 2007; Malanchi et al., 2008). In 
another example, mice with depleted TCF-4 completely lost the stem cell 
compartment of the small intestine (Korinek et al., 1998). Later research identified 
that Wnt signaling controls intestinal stem cell renewal, in cooperation with Bone 
- 9-
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Morphogenetic ~rotein cBMP) signaling (He et al., 2004b ). 
Recent evidence implicated Wnt signaling in heart stem cell renewal 
and differentiation. For instance, the defective regeneration of zebrafish heart was 
observed following the inhibition of Wnt signaling by the inhibitor DKK (Stoick-
Cooper et al., 2007). Another research group identified that the multi potent isll ( +) 
cardiovascular progenitors can differentiate into the three major heart cells 
including cardiac, smooth muscle, and endothelial cells (Moretti et al., 2006). 
More recent studies from the same lab demonstrated that Wnt signaling regulates 
the regeneration and differentiation of isll ( +) cardiovascular progenitor cells 
during cardiogenesis (Qyang et al., 2007). The activation of Wnt signaling by 
introducing Wnt-3a ligands into isll(+) progenitor cells of the secondary heart 
field could inhibit the progenitor cell differentiation and thus result in the 
accumulation of isll(+) progenitors. This inhibition effect on heart stem cell 
differentiation gave rise to a defective morphology of outflow tract (OFT) in the 
heart. 
1.1.3 Wnt Signaling and Cancer 
The previous section discussed the important roles of Wnt 
signaling in normal animal development. However, the desregulation of Wnt 
signaling is associated with a number of malignancies, such as colon cancer (de 
- 10-
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Lau et al., 2007; Hadjihannas et al., 2006), ovarian cancer (Boerboom et al., 2005), 
breast cancer (Benhaj et al., 2006), melanoma (Larue and Delmas, 2006; 
Murakami et al., 2001 ), and prostate cancer (Chen et al., 2004; Lu et al., 2009; 
Verras and Sun, 2006). Familial Adenomatous Polyposis (FAP), for example, is a 
hereditary disease with inactivating mutations of the human APC gene. Patients 
presenting with multiple pre-malignant lesions such as aberrant crypt foci and 
small polyps in the intestine (Gaspar et al., 2008; Powell et al., 1992; Seno et al., 
2002) may develop into multiple colonic adenomas (Groden et al, 1991; Hinoi et 
al., 2007; Zauber et al., 2003). Polyps may also occur in the upper gastrointestinal 
tract and carcinomas may also develop in the brain and thyroid gland in patients. 
Compared to FAP, fOlorectal fancer (CRC) is a more frequently 
occurring disease, and up to 85% of all sporadic CRCs contain loss-of-function 
mutations in the APC gene (Giles et al., 2003 ; Joyce and Pintzas, 2007; Segditsas 
and Tomlinson, 2006). These alterations, including insertions, deletions, and 
nonsense mutations in the APC gene give rise to the retention of P-catenin and 
deregulation of Wnt target genes. In addition, the gain-of-function mutations in P-
catenin itself and the inactivating mutations of axin have been identified in 
approximately 10% of the remaining CRCs and a few CRC cell lines (Webster et 
al., 2000), providing support of the hypothesis that mutations causing stabilized 
nuclear P-catenin may be sufficient for the development of colonic neoplasms. 
- II -
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Activating mutations of the Wnt pathway are not restricted to CRCs. 
Upper gastrointestinal tumors, for instance, contain a high number of ~-catenin 
mutations (Lynch et al., 2005; Ogasawara et al., 2006). Also, mutations occurring 
in the key mediator ~-catenin itself are associated with neoplastic transformation 
in one subtype of epithelial ovarian cancer (Zhai et al., 2002), which will be 
discussed in the next section. 
The identification of Wntl , originally called int-I , as an oncogene in 
mouse breast tumors attracted researchers' interest to investigate the association of 
Wnt signaling with breast cancer. Different from other cancers, evidence is lacking 
to conclude that the deregulation of Wnt signaling in human breast cancers is 
entirely due to mutant APC, Axin or ~-catenin (Howe and Brown, 2004; Ueda et 
al., 2001 ). A recent study on human breast cancer cell lines found accumulated ~­
catenin in nuclei and up-regulated expression of the Wnt target gene cyclin D 1. 
The overexpression of multiple Wnt ligands and receptors observed in this study 
may account for the activation of Wnt signaling in human breast cancer cells 
(Benhaj et al., 2006). 
1.1.4 Wnt Signaling and Epithelial Ovarian Cancer 
Carcinomas are referred to as cancerous epithelial tumors. 
Approximately 85%-90% of ovarian cancers are gpithelial Ovarian Carcinomas 
- 12 -
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(EOC) (Auersperg et al., 2001; Landen et al., 2008), a deadly gynecologic 
malignancy that is derived from transformation of ovarian surface epithelial cells. 
Patients diagnosed with EOC are mostly at an advanced stage since early stage 
disease is usually asymptomatic, limiting the median survival time to less than 2 
years (Jemal et al., 2007). EOC tumors become refractory to most available 
chemotherapy drugs and the recurrence rate is close to 100% (Christie and Oehler, 
2006; Jemal et al., 2007). In addition, EOC is histologically categorized into at 
least 5 distinct subtypes: serous, mucinous, endometrioid, clear cell and 
undifferentiated. The undifferentiated epithelial ovarian carcinomas tend to 
proliferate and spread most quickly (Christie and Oehler, 2006). 
Understanding the mechanism of this disease is important to improve 
treatment options. Although the Wnt signaling pathway plays an important role in 
many malignancies, such as colorectal cancer (Verma et al., 2003), breast cancer 
(Benhaj et al., 2006) and hepatocellular carcinoma (Kim et al., 2008), in EOC, 
only one cell line of endometrioid origin has been shown to display high levels of 
constitutive Wnt signaling (Kildal et al., 2005; Zhai et al., 2002). Cell lines 
derived from the other four EOC subtypes do not. These observations suggest that 
Wnt signaling is important only in one subtype ofEOC tumors. 
1.2 Human Pygopus2 (hPygo2) in Epithelial Ovarian Cancer 
- 13 -
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1.2.1 Pygopus proteins and their functional domains 
Pygopus is a component of the P-catenin/TCF transcriptional complex 
essential for activation of Wnt signaling pathway. The extreme similarities in 
phenotypes between Pygo mutants and other W g signaling mutants resulted in the 
identification of the prototype Pygopus protein in Drosophila ( dPygo) (Kramps et 
al., 2002; Parker et al. , 2002; Thompson et al., 2002). A yeast-two-hybrid assay 
initially showed that the legless protein (Drosophila homolog of human BCL-9) 
interacted with Pygo (Kramps et al., 2002) and thus may link Pygo to P-catenin. 
Subsequent studies revealed that Pygo may function as an anchor for the nuclear 
retention of P-catenin which is mediated by Legless (Krieghoff et al., 2006; 
Townsley et al., 2004; Tolwinski and Wieschaus, 2004). Alternatively, a "Pygo-
>legless->P-catenin" chain protein complex was proposed by which Pygo and 
Legless conferred their co-activator function to P-catenin for activating Wnt gene 
transcription (Hoffman et al., 2005; Stadeli and Basler, 2005). 
dPygo contains several conserved regions corresponding to its 
vertebrate counterparts. In Xenopus, two Pygopus isoforms, a- and P- were found 
to be required for the development of the normal body axis (Belenkaya et al., 2002) 
and brain patterning (Lake and Kao, 2003). Human pygopus proteins have two 
versions, -1 and -2, abbreviated as hPygol and hPygo2 hereinafter (Figure 1.3). 
hPygo 1 and hPygo2 
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Figure 1.3 Conserved domains of Pygopus proteins in different species. 
Top Panel: Pygopus proteins contain several conserved domains including the 
Nuclear Localization ,S.equence (NLS, green color), NHD domain (blue color), 
and PHD domain (brown red color) in different species such as Drosophila, 
Xenopus, Mouse, and Human. Bottom Panel: Conserved amino acid 
sequences among different species (Cited from Li et al., 2004. Cloning and 
developmental expression of mouse pygopus 2, a putative Wnt signaling 
component. Genomics. 84: 398-405). 
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proteins, like dPygo, share several conserved domains. For example, at the C-
terminus, they contain a highly conserved zinc-binding domain known as the :r_lant 
Homeodomain (PHD) fmger. In Wnt signaling, the PHD of Pygopus directly 
interacts with HD1 domain ofLegless/BCL-9 (Kramps et al., 2002). Four specific 
residues (corresponding to hPygo2: Met361 , Thr362, Ala365, Leu369) within the 
PHD domain of Pygopus (Figure 1.4) are required for its association with BCL-9 
to form the ~-catenin/TCF transcription complex and thus functions as a co-
activator in transmission ofWnt signals (Townsley et al., 2004). 
The PHD finger motif was found in proteins that participate m 
chromatin remodeling (Aasland et al., 1995). Chromatin remodeling requires 
loosening and reorganizing the nucleosome structure, namely the histones and 
condensed DNA complex (Ausio et al., 2003). This may be achieved by 
modifications on Histone proteins such as the addition of methyl groups 
(methylation) or acetyl groups (acetylation) by the appropriate methytransferases, 
acetyltransferases and other chromatin remodeling factors to specific residues on 
exposed core histone tails (Sterner et al., 2000). For example, the SET1-type 
methyltransferase complex can promote the trimethylation of the histone H3 tail at 
lysine 4 (H3K4me3) (Sierra et al., 2006). The PHD fingers from a variety of 
chromatin remodeling proteins such as BPTF (Li et al., 2006), ING2/Yng1 (Pena 
et al., 2006), and RAG2 proteins (Ramon-Maiques et al., 2007) can specifically 
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Figure 1.4 Structural domains of human Pygopus 2 Protein (hPygo2). 
hPygo2 protein contains conserved domains including the NLS (green color), 
NHD domain (N-terminal, blue color), and PHD domain (C-terminal, brown 
red color). A NPF (Asn76, Pro77, and Phe78) motif in the NHD domain was 
found to have strong transcriptional activity. In the PHD domain of hPygo2, 
four amino acids in Drosophila corresponding to the residues (Met361 , 
Thr362, Ala365, and Leu369) have been shown to be critical for its interaction 
with BCL-9 (Legless in Drosophila) protein and required for Wnt gene 
transcription and embryonic development. 
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and selectively bind to the lysine 4 trimethylated histone H3 tail. Interestingly, a 
complex consisting of the PHD of Pygo and HD 1 of BCL9 can specifically bind to 
H3K4me3, suggesting that this interaction may link chromatin remodeling with 
Wnt target gene transcription (Fiedler et al., 2008). 
Other conserved domains of Pygopus are the N-terminal homology 
domain (NHD), adjacent to anN-terminal Nuclear Localization Sequence (NLS) 
(Li et al., 2004; Stadeli and Basler, 2005). The NHD and NLS domains are linked 
to the C-terminal PHD finger region by a long proline-rich non-conserved domain. 
Wnt target gene transcription not only depends on the interaction of Pygo PHD 
with legless/BCL-9 to form the Pygo>BCL9>~-catenin>TCF transcriptional 
complex, but also requires the regulation of a functional NHD domain. The NHD 
domain exhibits strong transcriptional activity dependent on a conserved NPF tri-
peptide (Asn76, Pro77, and Phe78) (Figure 1.4) and site-mutations within this NPF 
motif abolishes its transcriptional activity in vitro as well as dramatically decreases 
Wnt signaling in vivo (Stadeli and Basler, 2005). The mechanism by which the 
NPF motif confers transcriptional activity to the NHD, however, is lacking. 
Several possibilities were discussed recently for the activity of the 
NHD. Firstly, it was reported by de la Roche and Bienz (2007) that Pygo 
constitutively associated with dTCF in Drosophila tissue cultured cells and 
salivary glands which depended on the NHD of Pygo but not on legless. These 
- 18-
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researchers also modified the former accepted model of TCF transcriptional 
machinery and proposed that Pygo associated with dTCF at the "off' stage of Wnt 
signaling and indirectly brought ~-catenin in a legless-dependent manner to dTCF 
following Wnt stimulation. 
A subsequent study identified that the Medl2 and Med13 
components, encoded by skd and kto genes in Drosophila, are required for Wnt 
target gene transcription. These two components are subunits of the mediator 
complex crucial for the RNA polymerase II-dependent gene transcription. skd and 
kto mutant flies displayed absent expression of Wnt target genes even when the 
constitutively active form of Armadillo (Drosophila homolog of ~-catenin) was 
expressed, suggesting that these two genes functioned as further downstream 
components of ~-catenin in Wnt signaling. This study also demonstrated that 
Med12 and Med13 were required for the transcriptional activity of Pygo NHD. 
The indirect interaction of Med12, 13 with the Pygo NHD determined by GST-
pulldown and coimmunoprecipitation assays suggested that there may be some 
intermediate factors connecting the Med 12&13 to the Pygo NHD (Carrera et al., 
2008). 
Direct interaction between the Pygo NHD and the ETO domain of 
TAF4 was demonstrated in early 2009. TAF4 is a subunit within the TFIID 
complex of the basal transcription machinery. The TFIID complex, composed of 
- 19-
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TATA-binding protein (TBP) which has promoter recognition activity and TBP-
associated factors (TAFs) with co-activator functions, can bind to the promoter 
and enhancer regions of DNA and assist the initiation of RNA polymerase II-
dependent transcription. The well established Wnt target gene nkd was used to 
reflect the activation of Wnt signaling and deletion mutation analysis of TAF4 
identified the ETO domain at theN-terminal region of TAF4 was required for nkd 
expression under Wnt stimulation by an active form of Armadillo (Wright and 
Tjian, 2009). 
1.2.2 hPygo2 is required for EOC growth in the Absense of Wnt Signaling 
As mentioned in section 1.1.4, EOC can be divided into 5 histological 
subtypes. While Wnt signaling is restricted mainly to the endometrioid subtype 
(Kildal et al., 2005; Zhai et al., 2002), hPygo2 is unexpectedly overexpressed in all 
subtypes of EOC (Popadiuk et al., 2006) (Figure 1.5). hPygo2 is overexpressed in 
six malignant EOC cell lines and in the nuclei of 82% of 125 archived patient 
EOC tumors as compared to immortalized normal ovarian surface epithelial cells 
or benign disease tissues. These EOC cell lines and tumor tissues were derived 
from all 5 histological subtype origins including not only the Wnt-active 
(endometrioid) subtype but Wnt-inactive (other subtypes) origins. Furthermore, 
the depletion of hPygo2 protein in the EOC cell lines halted cell growth, 
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Figure 1.5 A. EOC subtypes and EOC cell lines. EOC has 5 major 
histological subtypes: endometrioid, clear cell, serous, mucinous, and 
undifferentiated. Cell lines including TOV-112D, TOV-21G, SKOV-3, ES-2, 
and OV-90 were derived from and represent each of these subtypes, 
respectively. Constitutive activation of Wnt signaling is only restricted to one 
subtype ( endometrioid). All the other subtypes exhibit either very low level or 
inactive Wnt signaling properties. B. The protein expression of hPygo2 in 
EOC cell lines (lmmunoblot). hPygo2 protein is overexpressed in all Wnt-
active and Wnt-inactive EOC cell lines comparing to non-malignant human 
ovarian surface epithelial cells. (Popadiuk et al., 2006) 
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suggesting its requirement for cancer growth regardless of Wnt signaling status 
(Popadiuk et al, 2006). An hypothesis was then proposed in which hPygo2 might 
play essential roles in EOC, independent ofWnt signaling. 
The notion that Pygopus has roles in the absence of, or independently 
of Wnt signaling was supported by experiments in embryonic development. Wnt-
independent roles of Pygo2 in lens development were revealed using a conditional 
Pygo2 knockout mouse model (Song et al., 2007). It was observed that deprivation 
of Pygo2 caused a microophthalmia phenotype by reducing expression of the Pax6 
gene required for lens development in the Pygo2·/- null mice. Since the conditional 
deletion of P-catenin in mice did not produce similar lens defects to Pygo2·/- null 
mice, the authors proposed that Pygo2 has crucial functions in lens development in 
a Wnt-independent manner (Song et al., 2007). These observations were consistent 
with previously published work in our lab in which the NHD of Pygo2 alone was 
able to restore eye and head patterning gene expression in Pygo2 deficient 
Xenopus embryos (Lake and Kao, 2003). 
Thus, evidence from both cancer and embryonic development 
strongly suggest that Pygopus has functional roles which are independent of Wnt 
signaling. How these requirements are fulfilled mechanistically is not completely 
known. 
-22 -
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1.3 Purpose of the Thesis 
The purpose of my thesis was to investigate the role of hPygo2 protein 
in EOC cancer cells independent of Wnt signaling. The following three major 
objectives were proposed in my thesis to address the hypothesis that hPygo2 fulfils 
Wnt-independent functions in EOC via interacting with factors not related to Wnt 
signaling. 
Objective 1). Determine the function of each domain of hPygo2 protein in EOC 
cell proliferation in the absence of Wnt signaling. 
Objective 2). Identification of hPygo2 interacting proteins in Wnt-inactive cell 
lines. 
Objective 3). Characterization of the interactions between potential proteins and 
hPygo2 
-23-
2.1 Cell Culture 
Chapter2: Materials and Methods 
CHAPTER2 
MATERIALS AND METHODS 
The epithelial ovarian cancer (EOC) cell line SKOV-3 and cervical 
cancer cell line HeLa were purchased from American Type Culture Collection 
(Manassas, VA). All the cells were cultured in Dulbecco's Modified Eagle's 
Medium (DMEM) (Gibco) supplemented by 10% fetal bovine serum (FBS) 
(Gibco), 100 units/ml penicillin, and 100 1-!g/ml streptomycin; and maintained 
in a humidified atmosphere with 5% C02 at a temperature of3rC. 
2.2 Western Blotting 
Total proteins from tissue cultured cells were extracted in cell 
culture lysis reagent (CCLR) (Promega). Protein concentration was measured 
using the Bio-Rad assay reagent (Anon, 1991). Approximately 50!-!g of total 
cell lysate was loaded per sample onto a 10% SDS-denaturing polyacrylamide 
gel. Separated proteins were then transferred (blotted) to nitrocellulose 
membranes (Hybond-ECL ™, Amersham). Blots were probed using hPygo2 
rabbit antisera (Hausenfeffer-314B) (Andrews et al., 2007) or anti-treacle lgY 
(Abeam) antibodies, and then visualized by enhanced chemiluminescence 
(Amersham). Blots were reprobed with either monoclonal anti-~-actin (Sigma) 
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or polyclonal anti-ERK.l to further confirm the equal loading of total protein as 
described (Popadiuk et al., 2006). 
2.3 Cell Rescue Asssay 
In brief, SKOV-3 cells were seeded in triplicate at a density of 
4x104/well in 12-well plates 24 hours prior to transfection of plasmid 
constructs (cloned in pCS2+ vector) expressing either wild type hPygo2 or 
hPygo2 mutants with mutations within the NIID or PHD domain, respectively 
(Figure 2.1A.). The next day, Phosphorothioate Antisense oligos hPy-ON8 
(Invitrogen) (5' -C*C*T*CTGGCCAGAAAC*T*T*T-3 '; * represents a 
phosphorothioate bond) specifically targeting the 3' UTR of hPygo2 mRNA 
(Figure 2.1B) was transfected to deplete endogenous hPygo2 protein (Popadiuk 
et al. , 2006). It contains phosphorothioate modifications on 3 mers of each end 
marked in bold dark font. The mismatched (5'-G*C*C*TGAGCTAATCATT 
*G*T*T-3') (Invitrogen) phosphorothioated oligos (MM oligos) which 
presumably are unable to bind hPygo2 mRNA and have no knockdown activity, 
were used as a negative control (Popadiuk et al. , 2006). Cell growth was 
assayed by cell counting using a hemacytometer 24 and 48 hours after 
transfection of the Antisense or MM oligos. Cell numbers are the average from 
3 independent experiments. Western blots were performed to determine the 
endogenous and exogenous hPygo2 protein levels. Rescuing 
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Figure 2.1 A. Rescuing plasmids. The DNA sequences of hPygo2 wild-type 
coding region were amplified and inserted into pCS2+ plasmid vector. Site-
mutations were made in the PHD or NHD domain of hPygo2 using this 
pCS2+ lhPygo2 wildtype coding region plasmid as a template. All wildtype and 
mutant plasmids were used for the rescue assay. B. Antisense Oligos for 
depleting hPygo2 protein. Antisense Oligos hPy-ON8 specifically targeting 
3 ' -UTR of hPygo2 rnRNA were used to knockdown the endogenous hPygo2 
expression in the rescue assay. 
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plasmids, Antisense and MM Oligos used in the cell rescue assay are shown in 
Figure 2.1A and B and described in detail below. 
2.3.1 Plasmid constructs 
All the plasmid constructs (Figure 2.1) were transfected at 150ng/well 
via Effectene® Transfection Reagent (Qiagen) as per the manufacturer 's 
protocol. 
1) pCS2+ empty vector (as a negative control): generously provided by Dr. 
Dave Turner, the Department of Biological Chemistry, University ofMichigan. 
2) pCS2+/hPygo2 coding region (as a positive control): Engineered by 
Phillip Andrews. 
3) pCS2+ /hPygo2 PHD mutant: Using pCS2+ lhPygo2 as a template, two 
PHD mutants were generated by Quik-Change® XL Site-Directed Mutagenesis 
Kit (Stratagene ). The first one contained a leucine to alanine alteration at 
position 369 within the PHD domain termed "hPygo2 L369A". The other one, 
named "hPygo2 T362A, A365V", had combinational two sites mutations in 
which the threonine residue at position 362 was altered to an alanine and the 
alanine residue at position 365 was changed to valine. The dual-site mutant was 
more efficient for abolishing the interaction with BCL-9 (see results section 3.1) 
and was therefore used for the rescue assay. 
4) pCS2+/hPygo2 NHD mutant: TheN-terminal homology domain (NHD) 
of Pygopus was previously shown to exhibit strong transcriptional potential a 
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dependent on a conserved NPF tri-peptide (corresponding to the amino acids 
Asparagine, Proline and Phenylalanine at position 76-78 of hPygo2) (Stadeli 
and Basler, 2005). Here also using pCS2+/hPygo2 wildtype as a template, these 
three residues at position 76-78 were all mutated into Alanines by 
QuikChange® XL Site-Directed Mutagenesis Kit (Stratagene). 
2.3.2 Antisense Oligonucleotides 
Either phosphorothioated Antisense oligos hPy-ON8 or MM control 
oligos were transfected at a fmal concentration of 250nM via Effectene® 
Tranfection Reagent (Qiagen). Media were changed 24 hours after transfection. 
2.3.3 Experimental groups 
All the experimental groups are indicated in Table 3.1. Group 1 and 2 
are co-transfections of pCS2+ empty vector with either Antisense oligos 
hPy-ON8 or MM Oligos. Group 3 and 4, 5 and 6, and 7 and 8 are 
co-transfections of pCS2+ hPygo2 wildtype coding region, pCS2+ hPygo2 PHD 
mutant and pCS2+ hPygo2 NHD mutant respectively with either Antisense 
oligos hPy-ON8 or MM Oligos. 
-28-
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Table 2.1 Experimental groups of co-transfections 
~ Rescuing plasmids Oligonucleotides 
1. EV+AS pCS 2+ Empty Vector (EV) Antisense oligos hPy-ON8 
2.EV+MM pCS2+ Empty Vector (EV) MM oligos 
3. WT+AS pCS
2
+ lhPygo2 Antisense oligos 
Wildtype Coding Region (WT) hPy-ON8 
4.WT+MM 
pCS2+ lhPygo2 
MM oligos Wildtype Coding Region (WT) 
5.PIID Mut 2+AS pCS
2
+ I hPygo2 PIID mutant 2 Antisense oligos 
(T362A, A365V) hPy-ON8 
6.PIID Mut 2+MM pCS
2
+ I hPygo2 PIID mutant 2 MM oligos (T362A, A365V) 
7.NIID Mut+AS pCS
2
+1 hPygo2 NIID mutant Antisense oligos 
(NPF76-78AAA) hPy-ON8 
8.NIID Mut+MM pCS
2
+1 hPygo2 NIID mutant MM oligos (NPF76-78AAA) 
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2.4 Mass-spectrometry 
2.4.1 Production of GST-fusion Proteins 
DNA sequences encoding only the hPygo2 NHD or PHD domain 
were amplified using the following PCR primers: NHD---forward, 
5 ' -GCGAATTCGTCCCCCACTCCATGGCCGCCTCG-3 '; reverse, 
5 '-GCCTCGAGCCAAGGAATGGAGGGGCTGCAAC-3' ; PHD--- forward, 
5 '-CGGAATTCATGGCTCCAAAGAAGAAGCGTAAGGTAC-3 '; reverse, 
5' -GCCTCGAGTCACCCATCGTTAGCAGCC-3'; and were inserted into 
EcoRI!Xhoi restriction sites of the pGEX 4 T-1 vector containing the 
Glutathione S Transferase (GST) tag. The resulting products were then 
mini-prepped using Wizard Plus SV Miniprep Kit (Promega) and sequenced 
using an Applied Biosystems 3730 DNA Sequencer (Sequencing performed by 
Dr. Elizabeth Perry in the Genomics and Proteomics (GaP) Facility, Memorial 
University). Plasmids pGex-4T-1-NHD and pGex-4T-1-PHD were transformed 
into BL-21 Codon Plus RP competent E.coli cells (Stratagene) and grown in 
250 ml Luria-Bertani (LB) media supplemented with 50ug/ml ampicillin at 37 
oc for nearly 3 hours. O.lmM Isopropyl P-D-1-thiogalactopyranoside (IPTG) 
was added and the cells were allowed to grow an additional 3 hours for the 
production of GST fused proteins. The GST-fusion proteins were lysed from 
the BL-21 cells and collected in 1 xPBS solution supplemented with 1 xProtease 
Inhibitor (PI) and 0.1% Triton X-100. 
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2.4.2 GST-pulldown assay 
The rationale of the GST-pulldown assay is illustrated in Figure 2.2. 
The NIID or PIID domain of hPygo2 was fused into GST proteins respectively. 
The GST-Fusion-NIID or GST-Fusion-PIID protein was subsequently 
incubated with Glutathione Sepharose® 4B beads (Amersham) at 4°C for 1 
hour according to the manufacturer 's protocol. The beads were washed at least 
five times with GST pulldown buffer to avoid non-specific binding. Nuclear 
proteins were extracted from EOC SKOV-3 cells using the NE-PER™ Nuclear 
and Cytoplasmic Extraction kit (Pierce) and incubated with previous GST 
protein-containing beads for 3 hours. After washing the beads 10 times with 
buffer, proteins bound to the beads were resolved and separated by 10% 
SDS-PAGE. Gels were then stained with Coomassie Brilliant Blue (Sigma) 
followed by destaining in destain-buffer and visualized with a digital camera to 
analyze the protein bands. 
2.4.3 In-gel digestion and Mass-spectrometry 
The basic principal for protein identification by mass-spectrometry is 
that: 1) Each sample protein is digested and cleaved into smaller peptides; 2) 
Peptides are then ionized and selected peptides are fragmented to produce mass 
spectra while some of these peptides do not ionize. Other peptides are 
fragmented multiple times to generate multiple mass spectra; 3) Acquired 
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Figure 2.2. Diagram of GST pulldown assay. GST-Fusion Proteins were 
immoblized onto Glutathione Sepharose 4B beads and incubated with cell 
lysates, nuclear extraction proteins, or in vitro translated radiolabelled proteins 
to allow the interacting-proteins to bind. After washing the beads, bound 
proteins were eluted and loaded on SDS-PAGE and subsequently identified by 
Immunoblot or Mass Spectrometry. 
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mass-spectra are searched in a peptide sequence database; 4) The list of 
matched peptides is used to identify corresponding proteins. (Reviewed in 
Topaloglou, 2006) 
Differential bands representing differential proteins pulled down by 
GST-NHD or GST-PHD fusion proteins were compared and bands of interest 
were excised into silicon tubes. Proteins in each band were digested via the 
Trypsin Profile IGD kit (Sigma). The digested peptides were extracted in 0.1% 
trifluoroacetic acid and 50% acetonitrile, dried by Speed-Vacuum Method and 
identified by a Dionex Ultimate 3000 HPLC coupled with an Applied 
Biosystem QSTAR XL MALDI-TOF mass-spectrometry (Performed by Ms. 
Lidan Tao at the Genomics and Proteomics (GaP) Facility, Memorial 
University). Mass-Spectrometry results were analyzed by Analyst (Applied 
Biosystem) and MASCOT software and the best matching candidate proteins 
were profiled from Pubmed protein database. 
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2.5 Characterizing protein-protein interactions 
2.5.1 Immunfluorescence(IF) microscopy 
IF was performed as described (Popadiuk et al. , 2006). Briefly, cells 
grown on glass chamber slides were fixed in 4% paraformaldehyde (30 minutes) 
followed by 2xwashes with PBS and 3xwashes with 0.2% Triton-X 100/PBS 
(0.2% TPBS). Fixed cells were blocked in 5% normal goat serum (NGS) for 30 
minutes and incubated with primary Antisera (diluted in 1.5% normal goat 
serum/PBS) overnight. Cells were washed for 30 minutes in 0.2% TPBS and 
then incubated with secondary antibodies. 4',6-diamidino-2-phenylindole 
(DAPI) was used for nuclear staining. For biotinylated secondary antibody, 
samples were incubated with fluorescein isothiocyanate (FITC)-Streptavidine 
for 30 minutes at room tempreture. Lastly, stained cells were washed 3 times in 
0.1% TPBS with 10 minutes each time, mounted in 10% glycerol/PBS and 
viewed under fluorescence microscopy. 
2.5.2 Co-Immunoprecipitation (Co-IP) assay 
The Co-IP assay is a common method utilized for verifying 
protein-protein interactions. Typically, complexes encompassing protein of 
interest and its interacting proteins in cell lysates are captured by specific 
antibodies against the protein of interest, which are then immobilized on 
Protein A or G affmity beads. The interacting proteins are subsequently 
-34-
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elucidated by immuno-blot or Mass-spectrometry. 
For this experiment (Figure 2.3), SKOV-3 cell monolayers at 90% 
confluence were washed with PBS and lysed in 1 xTriton Media (1 xTM) with 
1 xPIJPMSF. They were then extracted in cell lysates and incubated with 
antibodies overnight at 4°C. The next day, Protein A or G Sepharose™ CL-4B 
(GE Healthcare) beads were added and incubated for one hour at 4°C followed 
by 10 times washes with 1 xTM. Beads were spun down and bound proteins 
were subsequently resolved in 2xSSB and loaded on 8% SDS-PAGE. Specific 
interacting proteins were probed using primary antibodies and detected by 
enhanced chemiluminescence (Amersham). 
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Figure 2.3 Diagram of Co-immunoprecipitation Assay. 1. Incubate the 
antibody against protein of interest with cell lysates; 2. Immobilize the 
antibody, protein of interest, and interacting protein complexes onto protein 
AJG beads; 3. Wash the beads to eliminate non-specific binding proteins; 4. 
Elute binding proteins and irnrnunoblot the interacting protein. 
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2.5.3 GST-pulldown assay with in vitro translated radiolabeled proteins 
The rationale of the GST-pulldown assay was discussed in section 
2.3.2, Figure 2.2. For this experiment, successive deletion fragments of hPygo2 
were PCR amplified (except GST-NHD32-47aa) and inserted into the EcoRI 
and Xhoi sites of pGex4T-l(Figure 2.4). PCR primers used in the construction 
ofhPygo2 deletion fragments are listed in Table 2.1. For the GST-NHD32-47aa, 
two oligonucleotides were directly annealed and formed double-stranded DNA 
fragments containing a 5' EcoRI site and a 3' Xhol overhang which can be 
inserted into pGex4T-1 vector. The above plasmid constructs were then used to 
produce corresponding GST-fusion proteins. 
Complementary full-length protein or fragments of specific 
domains which were identified to interact with hPygo2, were synthesized and 
radiolabeled using in vitro transcribed/translated TnT SP6 System kit (Promega) 
and incubated with previous GST-Fusion proteins. Bound proteins were 
isolated by SDS-PAGE and in vitro translated proteins were detected using 
autoradiography instead of irnmunoblots. 
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Figure 2.4 GST fused successive deletion fragments of hPygo2 protein. 
Successive deletion fragments of hPygo2 were PCR amplified and inserted into 
pGex 4T-1 vector. 1: empty vector that only produces GST tag protein; 2: GST-
fused PHD domain; 3: GST-Central (non-conserved) domain; 4 to 7: GST-
NHD, GST-NHDI-47aa, GST-NHD32-47aa, and GST-NHD48-95aa fusion 
proteins, respectively. 
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Table 2.2 Primers used for amplifying successive deletion fragments of hPygo2 
Construct Forward Primer Reverse Primer 
2. PHD 5' -CGGAATICATGGCTCCAAAGAAGAAGCGTAAGGTAC 5' -GCCTCGAGTCACCCATCGTIAGCAGCC 
3. t.Nt.P 5' -CGGAATICGCATCCAACCClTTIGAAGATGAC 5' -CGGTCGAGTCAGCCAGGGGGTGCCAAGCTGTIG 
4. NHD 5' -GCGAATICGTCCCCCACTCCATGGCCGCCTCG 5' -GCCTCGAGCCAAGGAATGGAGGGGCTGCAAC 
5 . NHDI-47aa 5' -GCGAATICGTCCCCCACTCCATGGCCGCCTCG 5' -GCCTCGAGCTTCCTTCGCTICTTITCTGGACTC 
6. NHD32-47aa 5' -AATTCAAGCAGGGCAAGGCCGGTCTGCAAAT- 5' -TCGAGCTTCCTTCGCTTCTITICTGGACTCTTC-
GAAGAGTCCAGAAAAGAAGCGAAGGAAGC ATTTGCAGACCGGCCTTGCCCTGCTTG 
7. NHD48-95aa 5' -GCGAATICTCAAATACTCAGGGCCCTGCATAC 5' -GCCTCGAGCCAAGGAATGGAGGGGCTGCAAC 
2.5.4 Actinomycin D (AMD) treatment 
HeLa cells were seeded in chamber slides and grown overnight in 
Dulbecco's Modified Eagle's Medium (DMEM) (Gibco) supplemented by 10% 
fetal bovine serum (FBS) (Gibco ), 100 units/ml penicillin, and 100 ~g/ml 
streptomycin; and maintained in a humidified atmosphere with 5% C02 at a 
temperature of 3rC. Next day, cells were treated with medium containing 
50ng/ml AMD for 2 hours at 37°C and analyzed by indirect 
immunofluorescence microscopy. Cells treated with medium containing 
Ethanol (vehicle for AMD) were used as controls. 
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The hPygo2 protein was originally identified as an essential co-
mediator in the canonical Wnt signaling pathway. It was later found overexpressed 
in and required for not only Wnt-active but also Wnt-inactive EOC cell growth 
(Popadiuk et al., 2006). The purpose of my thesis is to determine what is( are) the 
role( s) of hPygo2 in EOC cells in the absence of Wnt signaling. To this end, three 
objectives were proposed in my thesis: 1) determine which specific domain(s) of 
hPygo2 is(are) required for Wnt-inactive EOC cell growth using the cell rescue 
assay; 2) identify potential proteins interacting with this domain via proteomics 
technology; 3) characterize the interactions between potential proteins and hPygo2 
which are critical for EOC growth in the absence ofWnt signaling. 
3.1 Cell Rescue Assay 
Previous studies used cell rescue assays to demonstrate the 
specificity of the requirement of hPygo2 for EOC cell growth (Popadiuk et al, 
2006). Cell growth, as determined by EOC cell number, was significantly reduced 
when the level of hPygo2 was reduced by the transfection of phosphorothioated 
antisense oligonucleotides (oligos), which specifically targeted the non-coding 
sequences of hPygo2 mRNA. Cell growth arrest was prevented by the co-
transfection of plasmids expressing wild-type hPygo2 protein. 
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In an attempt to isolate which domain(s) ofhPygo2 is (are) required 
for Wnt-inactive EOC cell growth, I performed similar rescue experiments but co-
transfected mutant hPygo2 plasmids in which critical residues within the NHD or 
PHD domains were altered. From these experiments, the requirement of the 
domain(s) of hPygo2 for EOC cell proliferation could then be determined 
depending on whether or not mutations introduced in this domain disrupt the 
ability ofhPygo2 to restore growth from hPygo2-depleted SKOV-3 (Wnt-inactive) 
cells. In addition, the proline-rich domain linking the NHD to PHD of hPygo2 is 
not conserved among different species and has not exhibited any significant 
function in development and cancer. Therefore no mutant plasmids originating 
from this domain were involved in the cell rescue assays. 
3.1.1 hPygo2 PHD mutant can not bind human BCL-9 protein 
The Plant Homeodomain (PHD) ofPygopus directly interacts with the 
HDI domain of Legless/BCL-9 (Hoffinans and Basler, 2004; Townsley et al., 
2004), and functions as a canonical Wnt signaling-dependent co-activator for the 
~-catenin/TCF transcription machinery. Recent evidence also indicated that a 
complex comprised of the PHD of Pygo and HD 1 of BCL-9 can specifically bind 
to methylated lysine 4 residues on histone H3 tails suggesting its involvement in 
the initiation step of Wnt target gene transcription (Fiedler et al., 2008). 
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Specifically, four residues (corresponding to hPygo2: Met361 , Thr362, Ala365, 
Leu369) in the PHD domain were essential for the interaction of the PHD with 
BCL-9 in the ~-catenin!TCF transcriptional activation complex (Townsley et al., 
2004 ). Other than this association, very limited functions were demonstrated for 
the PHD. 
Because of their importance for the function of the PHD, the four critical 
residues within the PHD were selectively altered to generate hPygo2 PHD mutant 
proteins that were unable to bind BCL-9. A single-point mutant in which Leucine 
at position 369 was converted to Alanine (hPygo2-L369A) and a double-site 
mutant in which Threonine at position 362 and Alanine at 365 were altered to 
Alanine and Valine respectively (hPygo2-T361A, A364V), were made as 
described in section 2.4.1. To validate whether these mutants abolished the 
association with BCL-9, GST-pull down assays were performed using GST-fused 
above mutant proteins to test interactions with in vitro translated radiolabeled 
human BCL-9 proteins (hBCL-9). As shown in Figure 3.1 , the GST-fused 
wildtype hPygo2 protein (lane 4) interacted with radio labeled hBCL-9. This level 
of interaction was substantially diminished to approximately 50% after 
introducing the L369A mutation (laneS). In contrast, the Pygo2-T362A, A365V 
mutant had completely lost the potential to bind BCL-9 
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Figure 3.1 GST Pulldown Assay: GST-PHD double point mutant abolished 
the interaction with human BCL-9(hBCL9). Lane 1: 10% input of in vitro 
translated radiolabeled hBCL-9 protein (MW: approximately 170KDa); Lane 2 
and 3: GST alone and GST-NHD fragment proteins incubated with 
radiolabeled hBCL-9; Lane 4, 5 and 6: GST-hPygo2 wildtype, GST-hPygo2 
L369A single point mutant and T362A, A365V dual-site mutant incubated with 
radiolabeled hBCL-9 respectively. 
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(lane 6). Therefore, DNA sequences encoding the latter dual-site PHD mutant 
protein were subcloned into the pCS2+ expression vector and co-tranfected with 
hPy8-0N Antisense oligos to determine if it could rescue growth arrest in SKOV-3 
cells (see sections 2.4.1 and 2.4.3 for the experimental design and section 3.1.3 for 
the cell rescue assay results). 
3.1.2 Amino acid substitution of NPF to AAA abolished the transcriptional 
activity of hPygo2 NHD domain 
The N-terminal homology domain (NHD) of Pygopus exhibits 
strong transcriptional potential (Stadeli and Basler, 2005). A conserved NPF tri-
peptide within the NHD (corresponding to the amino acids Asn76, Pro77, and Phe78 
of hPygo2) was shown to be an essential motif for this activity, since site-
mutations within this motif resulted in substantial abolishment of transcriptional 
potential in vitro as well as a dramatic decline of Wnt signaling in vivo. Apart from 
this transcription potential very little activity of the NHD region was reported. 
In order to investigate whether the NHD was required for EOC 
growth, I mutated the NPF triplet motif of the NHD into three Alanine residues 
(NPF->AAA). As expected from previous studies (Stadeli and Basler, 2005), DNA 
tethered, Gal4 dependent transcription assays (performed in collaboration with P. 
Andrews, Appendix 1) showed that this NPF->AAA mutant was deficient in 
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transactivation activity. In these assays, the NPF->AAA NHD mutant fragment 
was fused to the GAL4 DNA binding domain (DBD), and its ability to stimulate 
transcription when co-transfected with the reporter plasmid, pFR-Luc was 
quantified in relative luciferase unit (RLU) values. It displayed approximately 
equal luciferase activity as compared to background obtained from Gal4DBD 
alone while the RLU values were increased over 2 fold when Gal4DBD-fused to 
wild-type NHD was expressed. These assays confirmed that the NPF motif is 
required for the transcriptional activity of the NHD ofhPygo2. 
3.1.3 A functional NHD domain is required for rescuing cell number decrease 
observed with Antisense treatment 
Previous studies demonstrated the specific requirement of hPygo2 
for EOC growth from the observation that wildtype hPygo2 had rescued cell 
growth (Popadiuk et al., 2006). In the present rescue experiments, co-transfecting 
the wildtype hPygo2 with the hPy8-0N Antisense Oligos was therefore included 
as a positive control. On the other hand, co-transfection of empty vector with the 
hPy8-0N Antisense Oligos was used as a negative control. The co-transfection of 
plasmids that encode either the hPygo2 PHD mutant or the NHD mutant proteins 
with Antisense oligos were individually compared (controlled) by co-transfecting 
them with Mismatched (MM) Oligos as the MM Oligos had no effect on hPygo2 
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protein levels and cancer cell growth (Popadiuk et al, 2006). 
Prior to determining the effects of these rescuing plasmids on cell 
growth arrest, western blots were performed not only to confirm that hPy8-0N 
Antisense oligos were able to deplete endogenous hPygo2 protein, but also to 
verify that the hPygo2 wildtype or mutant proteins were sufficiently expressed. As 
shown in Figure 3 .2A, the levels of endogenous hPygo2 protein were significantly 
decreased by the co-transfection of pCS2+ empty vector (EV) with the hPy-ON8 
Antisense Oligos (lane 1) as compared to the pCS2+ EV plus mismatched (MM) 
control oligos (lane 2). On the other hand, the loss of endogenous hPygo2 protein 
following Antisense treatment was compensated by the largely exogenous 
expression of hPygo2 wildtype (lane 3), PHD mutant (lane 5) or NHD mutant 
proteins (lane 7). Moreover, the hPygo2 wildtype (lane 4 ), PHD mutant (lane 6) or 
NHD mutant proteins (lane 8) were also significantly expressed when co-
transfected with MM oligos. 
The cell rescue assay results are shown in Figure 3 .2B. Consistent 
with previous studies, the co-transfection of pCS2+ EV with hPy8-0N displayed 
nearly 30% reduction (P<0.01) in the number of SKOV-3 cells 48 hours after 
transfection and about 20% reduction (P<0.01) after 72 hours (lane 1) as compared 
with the control treatment (pCS2+ EV plus MM oligos, lane 2). This implied that 
pCS2+ EV, as the negative control, was unable to recover cell growth from hPygo2 
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Figure 3.2A. Western blot for rescue assay. Cell lysates were extracted 
48hours after co-transfection. hPygo2 protein was detected with hPygo2 
polyclonal rabbit antisera (about 50KDa). ~-actin (47KDa) was re-probed to 
confirm the equal loading of total proteins. B. Cell Rescue Assay. Cell 
numbers counted in all the Antisense experimental groups were normalized by 
corresponding MM control groups. Colomns are the averages of three 
experiments repeated in triplicate; Bars, standard deviation. Unpaired t test 
were performed to determine statistical significance. A single star (P<O.OS) 
indicates significant difference and a double star (P<O.Ol) indicates very 
significant difference between the Antisense experimental groups and 
corresponding MM control groups. 
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knockdown. 
The co-transfection of pCS2+ /hPygo2 wildtype plasmids with hPy-
ON8 Antisense Oligos resulted in no significant difference (approximately 5% at 
48 hours, P=0.20; and 8% at 72 hours, P=O.l4) in SKOV-3 cell numbers (lane 3) 
in contrast to that of corresponding controls (pCS2+ lhPygo2 wildtype plus MM 
oligos, lane 4). 
Similar results were observed when hPygo2 PHD mutant protein 
(lane 5) was expressed after antisense treatment. There appeared to be either 
slightly (nearly 3%, P=0.82) more cells at 48 hours or slightly fewer cells (not 
statistically significant, P=0.43) at 72 hours in relation to control treatment (pCS2+/ 
hPygo2 PHD mutant plus MM oligos, lane 6),indicating that mutations on the 
critical residues within the PHD did not affect its ability to reverse the decrease in 
EOC cell numbers following antisense treatment. Thus, while the PHD domain is 
required for the interaction of Pygo with BCL-9, it is unlikely required for EOC 
cell growth, at least in the Wnt-inactive SKOV-3 cells. 
When hPygo2 NHD mutant proteins were co-transfected with 
antisense oligos into SKOV-3 cells, there were significantly fewer cells remaining 
(18% at 48 hours, P<0.05; 29% at 72hours, P<O.Ol ; Figure 3.2B, lane 7) as 
compared to those cells transfected with control reagents (pCS2+/hPygo2 NHD 
mutant plus MM oligos, lane 8). These findings indicate that mutation of the 
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NIID, but not the PHD disabled the ability of exogenous hPygo2 to restore SKOV-
3 cell numbers reduced by depletion of endogenous hPygo2. 
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3.2 Proteomics 
The cell rescue assays described previously (Section 3.1) 
demonstrated the requirement of the NHD of hPygo2 protein for SKOV-3 cancer 
cell growth. It is possible that mutation of the NPF motif within the NHD prevents 
interaction of Pygo with other proteins, and that these interactions are essential for 
cell growth. To begin testing this hypothesis, proteomics experiments were 
performed to identify candidate NHD-interacting proteins. These analyses were 
performed in collaboration with Phillip Andrews and Keelia Farrell. 
Our approach was to couple glutathione-S-transferase (GST)-
pulldown assays with Mass-spectrometry. In brief, GST alone, GST fused to the 
NHD (GST-NHD), GST fused to the NHD mutant (GST-NHD NPF->AAA), or 
GST fused to the PHD (GST-PHD) were immobilized into Glutathione Sepharose 
beads individually and then used to probe nuclear fraction proteins of SKOV-3 
cells. The nuclear proteins that specifically bound to GST-NHD, but not GST 
alone or GST-PHD beads, after stringent washes, were separated by SDS-PAGE 
and visualized by Coomassie Blue staining. The differential proteins pulled down 
by GST-NHD, but not GST-NHD NPF->AAA, indicate possible proteins that 
specifically associate with the NPF residues. These possible binding proteins were 1 
then digested, "in-gel", into peptides using the Trypsin Profile IGD digestion kit 
(Sechi and Chait, 1998) and analyzed by MALDI-TOF mass-spectrometry. 
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MASCOT software was then used to identify peptide sequences and search 
matched candidate proteins from the protein database at www.pubmed.com. 
Mass-spectrum analysis was repeated two times and no differential 
protein bands were visualized when comparing GST-NHD pulldown and GST-
NHD NPF -> AAA pull down. However, comparing the proteins that interact with 
GST-NHD, but not GST alone or GST-PHD, identified a number of candidate 
proteins including RNA binding protein p68, RNA helicase II/Gu, Nop56, and 
Treacle, which are briefly described below. These proteins that potentially interact 
with the NHD domain were identified in both repeated experiments. 
p68 is a member of the DEXD-box (Asp-Glu-Ala-Asp) family of 
RNA helicases involved in RNA metabolism such as RNA splicing and splicing 
site selection. It may also regulate gene transcription by binding to estrogen 
receptor a , p53, RNA polymerase II, MyoD and CREB binding protein (CBP) 
respectively and thus stimulate their functions (Caretti et al, 2006; Bates et al, 
2005; Guil et al, 2003 ; Liu 2002; Rossler et al, 2001; Rossow et al, 2003). Recent 
research has shown that p68 is overexpressed in colon cancer and can be a 
potential target for colon cancer treatment (Shin et al., 2007). The other study 
revealed that downregulating the p68 led to reduced splicing products of 32S pre-
rRNA which demonstrated the involvement of p68 in ribosomal biogenesis (Jalal 
et al, 2007). 
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RNA Helicase II/Gu is also a member of the DEAD-box family of 
proteins related to p68 and p72 RNA helicases. In addition to its involvement in 
RNA unwinding and RNA folding, it was shown to interact with c-Jun and 
stimulate c-Jun-mediated gene activation (Valdez et al., 2002). It was later found 
to participate in rRNA processing since siRNA mediated knockdown of RNA 
Helicase II/Gu caused significant inhibition of 28S and 18S rRNA production. 
This participation was also evident through functional interaction with ribosomal 
protein L4 (Yang et al, 2005). 
Nop56 is one of the four core small nucleolar ribonucleoproteins 
(snoRNPs) besides fibrillarin, Nop58 and 15.5 KDa proteins. They belong to the 
box C/D class of snoRNPs which direct the most common modification of 
ribosomal RNAs (rRNAs) known as 2' -0-Methylation (Gautier et al, 1997; Tran 
et al, 2003). 
As a nucleolar phosphoroprotein, Treacle is encoded by TCOF 1 gene, 
which is mutated in individuals with hereditary Treacher-Collins Franceschetti 
syndrome (TCS), an autosomal dominant disorder of craniofacial development 
(reviewed in Dixon et al, 2007). It was found localized in the nucleolar 
compartment in HeLa cells, interacting with upstream binding factor (UBF, a 
critical transcription factor for RNA polymerase I) and required for ribosomal 
RNA synthesis (Valdez et al, 2004 ). A recent study also demonstrated its 
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participation in pre-RNA methylation during ribosome biogenesis (Gonzales et al, 
2005a). 
In summary, our proteomic analyses suggested that the NHD of 
hPygo2 may interact with a variety of nucleolar proteins encompassing p68, RNA 
helicase 11/Gu, Nop56, and Treacle. Characterization of these interactions may 
contribute to reveal critical roles of hPygo2 in cancer cell proliferation. 
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3.3 Characterizing the Interaction between hPygo2 and Treacle 
Nucleoli are subnuclear compartments where ribosomal RNAs 
(rRNAs), signal recognition particles as well as proteins involved in gene 
expression and cell proliferation are synthesized. It is the center of ribosomal 
biogenesis which involves the process of rRNA synthesis, maturation, and 
assembly of rRNA and ribosomal proteins into the large and small ribosome 
subunits (Scheer and Hock, 1999; Carmo-Fonseca et al., 2000). Many of the 
identified nucleolar proteins are associated with human diseases (Pederson, 
1998; Visintin and Amon, 2000; Gonzales et al. , 2005a, b). 
In section 3.2, multiple nucleolar proteins were identified as 
highly probable candidates found in SKOV-3 nuclei that interact with the NHD 
of hPygo2. Among these candidates, Treacle protein was of particular interest 
due to its highest predicted possibility of interaction. This section will describe 
a series of analyses confirming the interaction of hPygo2 with Treacle and will 
begin to explore the possibility of hPygo2 participating directly in ribosome 
biogenesis. 
The Treacle protein is encoded by the TCOFJ gene. It is a 
nucleolar phosphoprotein, required not only for rRNA transcription by 
interacting with upstream binding factor (UBF) but also for early modification 
(methylation) of pre-rRNA (Gonsales et al, 2005a; Valdez et al, 2004). In 
humans, mutation of the TCOF 1 gene is associated with Treacher-Collins 
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Franceschetti syndrome (TCS) (Dixon et al, 2006), whereby affected 
individuals display an array of craniofacial defects (Dixon et al., 1997; Dixon 
et al., 2007; Isaac et al., 2000). The cellular origin of TCS is complex, but 
studies in mice indicate that TCOFJ is required for rapid proliferation of neural 
fold cells during a critical time of brain growth. This growth requirement is 
considered to be linked to the role of TCOFl protein (Treacle) in ribosomal 
biogenesis (Dixon et al., 2000). 
The observations m TCS and in TCOF ]-deficient mouse 
embryos are consistent with studies usingpygo2_1_ mice (Li et al. , 2007; Schwab 
et al., 2007; Song et al. , 2007), and Xenopus embryos in which Pygo2 was 
depleted using antisense morpholino technology (Lake and Kao, 2003). These 
Pygo-defective embryos displayed head defects analogous to both humans with 
TCS and TCOFJ-defective transgenic mouse models. Taken together with our 
proteomics data indicating that hPygo2 interacts with Treacle, these studies 
supported my hypothesis that hPygo2 may be involved in ribosomal biogenesis 
in addition to, or in lieu of its canonical role in TCF/P-catenin-mediated 
transcriptional activation. 
The following sections are focused on characterizing the 
interaction of Treacle with hPygo2, followed by further investigation of the 
involvement of hPygo2 in ribosomal biogenesis. This involvement may 
generally exist in highly proliferative cells, such as EOC (Popadiuk et al., 2006) 
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and breast cancer cells (Andrews et al, 2007) in which hPygo2 was shown to be 
required for their malignant growth. Therefore, the following studies included 
both (EOC) SKOV-3 cells and the well-established cancer cellline-HeLa cells 
derived from cervical carcinoma. 
3.3.1 Treacle interacts with hPygo2 in vivo in SKOV-3 and HeLa cells 
The physical interaction of Treacle and hPygo2 was further 
examined by co-immunoprecipitation (Co-IP) in SKOV-3 and Hela cells. Total 
SKOV-3 or Hela cell lysates were prepared and immunoprecipitated with 
hPygo2 polyclonal rabbit antisera (hPygo2 immune). The co-
immunoprecipitated proteins were separated by SDS-PAGE and analysed for 
the presence of Treacle by immunoblotting with anti-treacle chicken antibody. 
As shown in Figure 3.3, hPygo2 immunoprecipitated endogenous Treacle 
proteins in SKOV-3 cells (lane 3) and Hela cells (lane 6). SKOV-3 or Hela cell 
lysates were directly loaded as inputs to show the presence of endogenous 
Treacle protein (lane 1 and 4). In contrast, pre-immune rabbit serum used at the 
same concentration as the immune antisera did not precipitate any Treacle 
protein from the SKOV-3 (lane 2) and Hela cell lysates (lane 5). The above 
results clearly demonstrated that Treacle and hPygo2 interact, in vivo, in 
SKOV-3 and HeLa cancer cells. 
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Figure 3.3 Co-immunoprecipitation (Co-IP) assay for hPygo2 and Treacle 
in cancer cells. SKOV-3, and HeLa celllysates were incubated with either pre-
immune rabbit serum or hPygo2 polyclonal rabbit antisera (hPygo2 immune). 
Co-immunoprecipitated proteins were blotted with chicken anti-Treacle lgY. 
SKOV-3 cells: lane 1, cell lysate input; lane 2, IP with pre-immune; lane 3, IP 
with hPygo2 immune. Hela cells: lane 4, cell lysate input; lane 5, IP with pre-
immune; lane 6, IP with hPygo2 immune. 
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3.3.2 Treacle colocalizes with hPygo2 in the nucleoli of SKOV-3 cells 
Treacle was identified by mass-spectrometry as a candidate that 
interacts with the NHD domain of hPygo2 protein. To verify this possibility, 
the subcellular localization of both proteins was analyzed by 
immunofluorescence microscopy. SKOV-3 cells were fixed and incubated with 
hPygo2 polyclonal rabbit antisera (hPygo2 immune) and anti-Treacle chicken 
(lgY) antibody. The secondary antibody for the hPygo2 antiserum was a 
biotinylated goat-anti-rabbit immunoglobulin G (lgG), detected usmg 
fluorescein isothiocyanate (FITC)-linked Streptovidin. Cy3-conjugated to goat 
anti-chicken IgG was used to detect Treacle protein. Treacle was localized to 
nucleoli of SKOV-3 cells (Figure 3.4, red fluorescence) as expected (Valdez et 
al, 2004). hPygo2 (Figure 3.4, green fluorescence) was found colocalized in the 
nucleoli with Treacle. hPygo2 was also found in the perinuclear region of 
SKOV-3. 
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Figure 3.4. Treacle and hPygo2 colocalized in the nucleoli of SKOV-3 cells. 
SKOV-3 cells were indirectly stained with antibodies against Treacle (chicken 
anti-Treacle IgY, red) and hPygo2 (hPygo2 polyclonal rabbit antisera, Green). 
4',6-diamidino-2-phenylindole (DAPI) was used to indicate nuclear staining 
(blue). Scale bar, 1 0!-lm. 
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3.3.3 Mapping protein interaction domains 
The previous sections provided evidence that hPygo2 interacted 
with Treacle in cancer cells: immunofluorescence revealed that both proteins 
colocalized to nucleoli and Treacle co-immunoprecipitated in celllysates using 
antisera directed specifically against hPygo2. In this section, I described 
analyses where I used GST pulldown assays coupled with in vitro translated S35 
radiolabeled proteins to map the domains and/or regions required for the 
interaction between the two proteins. Mapping data is useful to determine the 
specific residues or protein sequence domains that are required for the function 
of the protein. 
Deletion mapping was performed to determine the sites within the 
NHD that are required for its interaction with Treacle (Figure 3.5). A series of 
truncated DNA sequences encoding fragments of the NHD (within residues 1-
95) were subcloned into pGex 4T-1 plasmid vectors. DNA sequences encoding 
the hPygo2 PHD (residues 312-406) or intermediate non-conserved domains 
(~NHDM>HD) (residues 96-311) were also subcloned into the pGex 4T-1 
vector to be used as negative controls. Corresponding GST-fusion proteins 
were produced as described as in section 2.5.3 (Figure 2.4 and Figure 3.5A). 
A eDNA clone containing the coding sequence of human TCOFJ, 
5' and 3' untranslated regions (eDNA in pCMV-SPORT6 vector, Clone ID: 
3921754) was purchased from Open Biosystems, Thermo Fisher Scientific, 
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Huntsville, AL. Radiolabeled full length Treacle was translated, in vitro, from 
this clone and then used to test all the GST-fusion proteins via autoradiography. 
It was loaded without incubation with any GST-fusion proteins as an input 
shown in lane 0 of Figure 3.5B. The result clearly showed that GST-NHD 
(Figure 3.5B, lane 4), but not GST alone, GST-PHD and GST-~NHD&HD 
(lane 1, 2, 3 respectively), could pull down in vitro translated Treacle protein. 
In addition, GST fused to residues 1 to 47 (GST-NHDaa 1-47, lane 5) and 
residues 32 to 47 (GST-NHDaaJ2-47, lane 6) of the NHD, but not GST-NHDaa 4&-
95 (lane 7), were able to pull down Treacle protein. The minimal region within 
the NHD required for interaction with Treacle, therefore, was narrowed down 
from the whole NHD domain to the region encompassing amino acid residues 
32-47. 
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Figure 3.5 Deletion mapping-GST Pulldown Assay. A. Schematic of the 
successive deletions of hPygo2 fused into GST. Approximately 1 J.lg of each 
GST-fusion product was examined on the gel. B. The GST fusion products and 
in vitro translated Treacle protein were used for Pulldown Assay. 35S labeled 
Treacle proteins which were pulled down can be presented in corresponded 
position by autoradiography. Lane 1: Treacle 20% input; Lane 2: GST; Lane 3: 
GST-PHD; Lane 4: GST-~NHDM>HD; Lane 5: GST-NHD; Lane 6: GST-NHD 
1-47aa; Lane 7: GST-NHD 32-47aa; Lane 8: GST-NHD 48-95aa. 
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Chapter 3: Results 
The above in vitro GST-pulldown assays suggested that Treacle 
can interact with a region consisting of 15 residues (residues 32-47) within the 
NHD domain of hPygo2. I next asked which region of Treacle is required for 
its association with hPygo2. To answer this question, DNA sequences encoding 
separate domains of Treacle were amplified using previous pCMV-
SPORT6/TCOFJ construct as a template, cloned into the pCS2+ plasmid vector 
and translated in vitro into radiolabeled protein fragments. As shown in Figure 
3.6B, multiple bands were detected for each in vitro translated protein fragment. 
One possible cause for the lower molecular mass proteins is due to partial 
protein degradation. Although multiple bands were detected, each uppermost 
(highest molecular weight) band is well matched to the expected size for each 
protein fragment. 
The GST-NHD fusion proteins were immobilized into 
Glutathione Sepharose beads and incubated with the radiolabeled Treacle 
fragments in a GST-pulldown assay. As shown in Figure 3.6C, in vitro 
translated and radiolabeled full length Treacle (1-1411aa, lane 1), C-terminal 
(954-1411, lane 4) and C-terminal+ last partial central domains (667-1411aa, 
lane 6) are able to bind the GST-NHD. On the contrary, neither the N-terminal 
(1-290aa, lane 2) nor the central (291-953, lane 3) domains of Treacle as well 
as N-terminal+the first partial central region (1-666, laneS) can associate with 
GST-NHD. These results indicated that the C-terminal domain (954-1411aa) of 
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Figure 3.6A.B. In vitro translated Treacle fragments. Different fragments of 
Treacle domains (A) were in vitro translated, loaded on SDS-PAGE gel and 
visualized by autoradiography (B). This B panel represents 20% input for the 
GST pulldown shown in C. C. Interaction of the hPygo2 NHD domain and 
Treacle fragments- GST Pulldown Assay. The GST-NHD fusion protein was 
used to test all in vitro translated radiolabeled full length Treacle or Treacle 
fragments as below: lanel , Full-length Treacle; lane2, N-terminal domain; 
lane3, Central domain; lane4, C-terminal domain; laneS, N-terminal+first half 
Central domains; lane6, C-terminal+last 1/3 Central domains of Treacle. 
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Treacle protein is required for its interaction with the hPygo2 NHD. 
3.3.4 hPygo2, Treacle and UBF co-segregated in Hela cells treated with 
Actinomycin D (AMD) 
A great deal of detailed information on the structure and function 
of the nucleolus as the machinery for ribosomal biogenesis has accumulated 
for many decades (Olson, 2004). The nucleolar compartment contains three 
ultrastructural subregions: the core region termed the fibrillar centre (FC), the 
dense fibrillar component (DFC) surrounding the FCs, and the most outer layer 
termed granular component (G). The transcription of ribosomal DNA (rDNA) 
by RNA polymerase I mostly occurs either in the FC or at the border of FC and 
DFC (Boisvert et al, 2007; Huang, 2002). The synthesized ribosomal RNA 
(rRNA) precursors including the 47S and 45S pre-rRNA transcripts undergo 
modifications, which typically include methylation and pseudouridylation. The 
modified precursors are then cleaved into 28S, 5.8S or 18S rRNA products 
mainly within the DFC region by recruiting early processing factors known as 
snoRNPs. The late processing events take place at the outer most layers, the 
GC region where cleaved rRNAs are assembled with ribosomal proteins into 
ribosome subunits. Assembled ribosome subunits are subsequently exported 
into nucleoplasm and cytoplasm for generating ribosomes (reviewed in 
Boisvert et al, 2007). 
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The ultrastructural organization of the nucleolus is related to the 
transcriptional activity of RNA polymerase I which was demonstrated by 
Actinomycin D experiments (Shav-Tal et al., 2005; Unuma et al, 1973). 
Actinomycin D (AMD) is a chemotherapy drug that directly binds to rDNA 
and inhibits the transcriptional activity of RNA polymerase I. It is well 
established that AMD treatment causes nucleolar components within the 
fibrillar (FC and DFC) subregions to re-orient into nucleolar "caps", which 
segregate from the granular(GC) components (Shav-Tal et al., 2005). The 
change in the localization of a protein upon AMD treatment depends on the 
functional step with which it is involved during ribosomal biogenesis (Smetana 
et al, 2001 ; Unuma et al, 1973). 
Upstream binding factor (UBF) combined with other basic RNA 
polymerase I factors form the transcriptional initiation complex with RNA 
polymerase I. Previous research used UBF as a contrast for investigating the 
localization of Treacle protein in HeLa cells with AMD treatment via 
immunofluorescence (Valdez et al, 2004 ). It has been shown that Treacle only 
co-segregated with upstream binding factor (UBF), but not with the rRNA 
processing factor RNA helicase II!Gua (one of the GC components), into the 
same subregion of nucleoli in HeLa cells treated with 50ng/ml AMD for 2 
hours. This study therefore suggested that Treacle was more likely to act as a 
fibrillar component that facilitates rRNA transcription or early pre-RNA 
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processing (modification) than functioning in rRNA late processing events 
such as splicing, cleavage or ribosome subunit assembly and export (Valdez et 
al, 2004). Later studies verified that Treacle was required for rDNA 
transcription and involved in pre-rRNA methylation (Gonzales et al. , 2005a). 
In this study, four nucleolar components including UBF, Treacle, 
Fibrillarin and B23 were used as markers to identify the subnucleolar 
localization of hPygo2. While UBF and Treacle represent transcription and pre-
rRNA modification (methylation) factors (Valdez et al, 2004; Gonzales et al, 
2005a), Fibrillarin is mostly involved in early splicing of pre-rRNA (Amin et 
al. , 2007; Chen and Huang, 2001 ; Tollervey et al, 1991 ), which is localized in 
the DFC region of the nucleolus. In contrast, B23 protein as a GC component 
is only recruited in late processing events and ribosome subunit assembly 
(Smetana et al, 2001 ). 
After AMD treatment (50 ng/ml AMD for 2 h) in HeLa cells, the 
above four markers were co-immunostained with hPygo2 individually and then 
viewed under confocal scanning fluorescence microscopy. As shown in Figure 
3.7, hPygo2 colocalized with UBF, Treacle and Fibrillarin, but not B23 in the 
nucleoli of untreated HeLa cells. In AMD treated HeLa cells, hPygo2 co-
segregated with Treacle and UBF to the same region at the nucleolar caps, 
which was distinct from Fibrillarin. B23 also re-localized to the nucleoplasm 
but was organized circumferentially around the nucleoli. It did not 
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Figure 3.7. hPygo2 co-segregated with Treacle and UBF in the Hela cells 
treated with AMD. HeLa cells were treated with 50ng/ml actinomycin D for 
2h, stained by indirect immunofluorescence and observed by confocal 
microscopy. Nucleoli (arrows) were shown in nuclei by Differential 
interference contrast (DIC) images. (A) Treacle (red) localization in untreated 
and treated cells is compared with hPygo2 (green); (B) UBF (red) localization 
in untreated and treated cells is compared with hPygo2 (green); (C) Fibrillarin 
(red) localization in untreated and treated cells is compared with hPygo2 
(green); (D) B23 (red) localization in untreated and treated cells is compared 
with hPygo2 (green). Scale bar, 1 OJ.Lm. 
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co-segregate with any of the markers, including hPygo2. These results 
suggested that hPygo2 is localized to the fibrillar region (FC and DFC), but not 
the GC subcompartment of nucleoli. 
Taken together with my results demonstrating strong interaction 
of hPygo2 with Treacle, these observations suggested that hPygo2 may be 
involved in ribosomal biogenesis by participating in either rDNA transcription 
or pre-rRNA modification. 
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hPygo2 protein is overexpressed and required for the growth of 
epithelial ovarian malignancies in the absence of Wnt signaling. Here in my thesis, 
I further identified that theN-terminal homology domain (NHD) of hPygo2, but 
not the Wnt-mediating PHD domain, is essential for the Wnt-independent EOC 
cell proliferation. In addition, I verified the strong interaction between the hPygo2 
NHD region and the Treacle protein. These results suggest that one of the Wnt-
independent functions ofhPygo2 is involved in ribosomal biogenesis. 
4.1 Cell Rescue Assay 
To investigate the potential roles of hPygo2 protein in the absence of 
Wnt signaling, I have conducted a cell rescue assay to determine which domain of 
hPygo2 is required for Wnt-inactive cell growth. In this assay plasmids expressing 
either hPygo2 or hPygo2 mutants were co-transfected with Antisense Oligos to 
observe whether they can recover the growth of hPygo2-depleted cells. 
The SKOV-3 cell line represents a Wnt-inactive EOC cell line, and was 
used as a model for rescue assays and proteomics assays to investigate the Wnt-
independent mechanism of hPygo2 protein for cancer growth. One of the plasmids 
that rescued growth of Antisense Oligo-transfected cells was a version of hPygo2 
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that contains alterations on the critical residues required by hPygo2 to interact wi~ 
lgs/BCL-9 within the PHD domain (Townsley et al., 2004 ). One possible caveat 
for using this plasmid in a rescue assay is that the critical residues may also be 
used by hPygo2 for its interactions with proteins besides BCL-9. Therefore, in the 
event that the PHD mutants could not rescue cell growth, I would not be able to 
distinguish whether it was due to the abolishment of the interaction with BCL-9 or 
with other, unknown proteins. However, this issue was largely abrogated since the 
rescue assay results indicated that the PHD mutant did efficiently rescue cell 
growth, similar to results obtained with the positive control-hPygo2 wildtype 
plasmid, suggesting that the interaction of hPygo2 with BCL-9 and its 
involvement in Wnt signaling are not necessary for EOC cell growth. 
The same issue may also be applied to the NHD mutant rescuing 
plasmid. The rescue assay results, however, showed that the NHD domain 
containing alterations in NPF motif, which previously was shown to be required 
for the transcriptional activity of hPygo2 (Stadeli and Basler, 2005), substantially 
lack the ability to rescue SKOV-3 cell growth, suggesting that it is required for 
growth. 
Another consideration with the rescue assay results is that the 
knockdown effects by Antisense Oligos hPy-ON-8 were not ideal (approximately 
20%-30%) even they are statistically significant. It might because those AS Oligos 
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were targeted to 3 ' -untranslated region (UTR), and not the coding region, and may 
not be able to efficiently suppress hPygo2 mRNA. Alternatively, small 
interference RNAs (siRNA) or small hairpin RNAs (shRNAs) targeting hPygo2 
mRNA could also be used to downregulate hPygo2 expression through a RNA 
interference pathway. (Chen et al., 2009; Hamilton and Baulcombe, 1999; 
Simpson et al., 2008) 
The western blotting assay was used to determine hPygo2 protein 
levels. In these analyses, it was not possible to distinguish the endogenous from 
exogenous hPygo2 protein because they were expressed at the same size in the 
experimental groups 3-8 (Figure 3.3A, lane 3-8). Alternate approach would be to 
use an epitope-tag-containing vector (Chavand et al., 2001) instead of the pCS2+ 
vector to construct rescuing plasmids and then the tagged-wildtype hPygo2 or 
tagged-mutant hPygo2 could be discerned from the endogenous protein by size or 
by an antibody specifically against the tag. However, the tag itself may affect the 
function of hPygo2 protein in cancer cells and therefore may significantly 
influence its rescuing ability. More tests using different tag-hPygo2 rescuing 
plasmids should be conducted. 
4.2 hPygo2 Interacting proteins 
The current understanding of the function of hPygo2 is that it is not 
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only a co-activator in the canonical Wnt signaling pathway but also a 
transcriptional regulator through Wnt-independent mechanisms (Hoffmans and 
Basler, 2004; Townsley et al., 2004; Popadiuk et al., 2006; de la Roche and Bienz, 
2007; Song et al., 2007). The possibility of hPygo2 involvement in a Wnt-
independent mechanism may due to transcriptional activity of its NHD. My cell 
rescue assay results suggested the importance of the NHD, especially the NPF 
motif, for EOC cell growth. 
I hypothesized that there are factors that specifically bind to the NPF 
residues required for the function of hPygo2. The GST fusion proteins including 
GST-NHD or GST-NHD NPF-AAA mutant were used to probe nuclear extracts of 
SKOV-3 cells, and I attempted to determine the proteins that bound to the NPF. 
However, perhaps due to the limited separation rate of one dimensional small-
sized SDS-PAGE gels and the low resolution of visualization by Coomassie blue 
staining, it was not possible to distinguish any protein bands that associated with 
the GST-NHD exclusive of the GST-NHD NPF-AAA mutant. Future experiments 
may involve the use of 2-dimension gel electrophoresis and/or staining approaches 
with higher resolution such as the silver staining method (Mortz et al., 2001 ). 
Although I was not able to find NPF specific binding factors up to 
present, in collaboration with my colleagues, we nonetheless identified several 
candidate proteins using proteomics technology including p68, RNA helicase 
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11/Gu, Nop56, and Treacle that interacted with the NHD domain of hPygo2. p68 
and RNA helicase 11/Gu both belong to the DEAD box (Asp-Glu-Ala-Asp) family 
of RNA helicases (Cordin et al., 2006). p68 is increasingly expressed during 
benign to malignant transformation in the colon which is very similar to the up-
regulation of hPygo2 protein in EOC cells as compared to normal ovarian 
epithelial cells. p68 interacts with ~-catenin directly and enhanced the ability of~­
catenin to activate Wnt target gene transcription, suggesting that p68 is very 
important for the activation of Wnt signaling in colon cancer (Shin et al., 2007). 
However, whether it interacts directly with hPygo2 in EOC has not been 
characterized. Furthermore, whether it plays the same crucial roles in the Wnt-
inactive EOC cells as in the colon cancer, or whether its interaction with hPygo2 
can promote oncogene transcription for EOC progression, needs to be resolved. 
RNA helicase 11/Gu is one of the nucleolar proteins whose function 
mainly involves RNA unwinding. It also has been identified as a cofactor for c-
jun-activated transcription (Valdez et al., 2002). It was reported to be involved in 
ribosomal RNA processing because its suppression by siRNA led to an 80% 
reduction in both 18S and 28S rRNA production. The underlying mechanism for 
this effect has not been identified (Yang et al., 2005). However, the function of 
RNA helicases Gu in ribosomal RNA processing may relate to another hPygo2 
interacting protein-Treacle which was characterized in this thesis and it is possible 
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that this Gu protein forms a complex with Treacle and hPygo2 to affect ribosomal 
biogenesis in cancer cells. Therefore, whether it is colocalized with hPygo2 and 
whether it interacts with hPygo2 to cooperatively regulate c-jun gene transcription 
and/or ribosomal RNA synthesis for cancer proliferation need to be further 
identified. 
In addition, Nop56 ts one of the core small nucleolar 
ribonucleoproteins (snoRNPs) belonging to the box C/D class of snoRNPs which 
direct the most common modification of ribosomal RNAs (rRNAs) known as 2' -
0-Methylation (Gautier et al, 1997; Tran et al, 2003). Proteomic analyses from 
other studies identified the interaction of Treacle with Nop56 associated pre-
ribosomal complexes (Hayano et al., 2003). Therefore, verification of the 
association of hPygo2 with Nop56 will suggest its possible involvement in pre-
rRNA modification (methylation). 
Nucleoli are very important subcellular compartments for producing 
ribosomal RNAs, signal recognition particles and regulatory proteins involved in 
cell proliferation. Many nucleolar proteins can regulate mitosis, cell-cycle 
progression and proliferation, relating the nucleoli to human disease. Therefore, 
the colocalization of Treacle and hPygo2 in the nucleoli and their in vivo 
association as determined by Co-IP assays in SKOV-3 and HeLa cells raises the 
intriguing possibility that their interaction plays critical roles for cancer 
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progression. I will discuss the significance of the interaction between hPygo2 and 
Treacle in the next section. 
4.3 The Significance of Interaction between hPygo2 and Treacle 
TCOF 1 encodes a nucleolar phosphoprotein called Treacle, which is 
mutated in patients with hereditary Treacher-Collins Franceschetti syndrome 
(TCS), an autosomal dominant, congenital craniofacial disorder. Most TCOF 1 
mutations identified in TCS patients likely result in truncated treacle products 
because of the occurrence of premature stop codons. TCS is suggested to be 
caused by haploinsufficiency or dominant-negative effects, which result in loss-of-
function and rapid digestion of truncated Treacle protein products (Dixon et al., 
2007; Isaac et al., 2000). 
The full length Treacle protein is spatiotemporally expressed in the 
neuroepithelium throughout the E8 stage and more strongly in the frontonasal and 
branchial arch mesenchyme at E9.5 in the mouse embryo (Dixon et al., 2006). It is 
required for the transcription of ribosomal RNA and the methylation of pre-rRNA 
in the growth of the developing anterior nervous system (Valdez et al., 2004; 
Gonzales et al., 2005a). 
Similarly, mouse Pygopus2 (mPygo2) is expressed starting at day E7 
and peaks at day El7 in the mouse embryo. It was observed within multiple 
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regions in the developing brain with the strongest expression at the mesencephalon 
(Li et al., 2004). Moreover, mPygo2-/- mice have severe brain defects or 
exencephaly phenotypes (Schwab et al., 2007) which resemble those of TCOF -/+ 
embryos (Dixon et al., 2006). The interaction of Treacle and hPygo2 characterized 
in this thesis is consistent with interdependent roles in embryonic development. 
The requirement of treacle for ribosomal RNA transcription in development and 
cancer cell lines (Valdez et al., 2004) suggests the intriguing possibility that a Wnt-
independent role of hPygo2 in cancer may relate to a role in Treacle-dependent 
rRNA transcription in development of the mammalian nervous system .. 
Further studies on the requirement of the interaction between Treacle 
and hPgyo2 proteins for EOC cell proliferation as well as head development are 
warranted. 
4.4 Future Directions 
Studies in my thesis indicated that the NliD domain of hPygo2 was 
required for Wnt-independent cancer cell growth and Treacle was identified as an 
NIID-interacting protein. Therefore, in future studies, an initial experiment to 
perform would be one designed to determine the cell growth requirements of the 
hPygo2-Treacle interaction. The minimal residues in the NliD of hPygo2 required 
for its interaction with Treacle could be identified. Similarly, identification of the 
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minimal residues within the C-terminal domain of Treacle protein required for 
interacting with hPygo2 will be necessary. Mutations of either interaction sites will 
be used in cell rescue assays as previously described in section 2.1. The results 
will be able to indicate if the interaction between hPygo2 and Treacle is required 
for cancer cell proliferation. 
Interestingly, the preliminary studies revealed that hPygo2 interacts 
with the C-terminal domain of Treacle from which most mutations in humans 
causing truncated proteins occurred. In addition, this domain is thought to be 
responsible for the nucleolar localization of Treacle protein (Winokur et al., 1998). 
Given the putative role for Pygopus as a nuclear "anchor" for transcriptional 
complexes (Townsley et al., 2004 ), it is possible that truncated treacle proteins 
resulting from C-terminal deletions fail to interact with Pygopus and therefore lose 
the ability to localize to nucleoli. Therefore, the requirement of the Pygo-Treacle 
interaction for retention of Treacle in the nucleoli should be evaluated. For 
instance, experiments could be designed to determine if the knockdown of hPygo2 
protein by Antisense Oligos or siRNAs prevents the normal localization of Treacle 
to nucleoli in cancer cells. Similarly, we could observe the localization of Treacle 
protein in Pygo-1+ transgenic mice. 
Lastly, my immunofluorescence, co-IP and actinomycin D 
experiments showed that hPygo2 interacted with Treacle in cancer cells and co-
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segregated with Treacle and UBF, but not fibrillarin or B23 following AMD 
treatment, suggesting that hPygo2 may be involved in rRNA transcription or early 
processing rather than late processing events. In order to determine if hPygo2 is 
involved in rRNA transcription, Antisense Oligos or siRNAs to knockdown 
hPygo2 can be transfected into SKOV-3 and HeLa cells. Production of rRNA 
could be determined by nuclear run-on-assays of the 45S pre-rRNA (Glibetic et al., 
1995), pulse-chase metabolic labeling of pre-rRNA (Hennning et al., 2003), or by 
RNase protection assay (Yang et al., 1998). Moreover, to investigate possible roles 
of hPygo2 in pre-rRNA methylation, pre-rRNA methylation assays can be carried 
out as described (Gonzales et al., 2005a) following hPygo2 knockdown. In these 
assays, the reduction in pre-rRNA production or pre-rRNA methylation levels will 
be expected when cancer cells are transfected with hPygo2 antisense oligos or 
siRNA. 
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Appendix 
Transcriptional Reporter Assays 
To determine transcription activity, Luciferase Assasys were performed 
as described (Andrews et al., 2008). The reporter plasmid, pFR-Luc (Stratagene), 
consists of the luciferase gene driven by Gal4-binding sites and a basic 
transcriptional promoter (TATATA). The genes of interest were cloned into pM-
Gal4 (Clontech) plasmid vectors expressing Gal4 DNA binding domain 
(Gal4DBD). When pFR-Luc is transfected into cancer cells, little or no luciferase 
is expressed as the background expression level for the cell line used. When it was 
co-transfected with previously constructed pM-Gal4 plasmids, luciferase gene 
expression was measured, resulting from the association of Gal4-binding sites 
with the Gal4DBD in fusion with protein products encoded by the genes of 
interest. Therefore, the transcriptional activity of genes of interest can be 
quantified by relative luciferase activity. 
For this thesis, MCF-7 cells were seeded in triplicate 24 hours before 
transfection at a density of 1.5x105 per well in 12-well plates. pM-Gal4 plasmids 
containing the genes of interest were co-transfected with pFR-Luc reporter 
plasmids into cells using Lipofectamine and Plus Reagent (Invitrogen). pRSV-~gal 
plasmids (Promega) expressing ~-galactosidase to determine transfection 
efficiency were also co-transfected. Luciferase activities were measured using a 
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luciferase assay reagent (Promega) and a Monolight 2010 Luminometer 48 hours 
after transfection according to the manufacturer's directions. Relative luciferase 
unit (RLU) values were normalized to ~-galactosidase activity in each sample. 
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Appendix Figure: NHD NPF -AAA mutant lost transcription activity 
determined by a transcriptional reporter assay. Gal4DBD alone (Column 
1), Gal4DBD in fusion with NHD wildtype (Column2), and Gal4DBD in 
fusion with NHD NPF-AAA mutant protein (Column 3) were co-transfected 
with pFR-Luc reporter plasmids into MCF-7 cells. RLU were measured and 
normalized to ~-galactosidase activity in each sample. (Data from Mr. Phillip 
Andrews) 
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